Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
101M
-
Number of holders
-
220
-
Total 13F shares, excl. options
-
70M
-
Shares change
-
+1.1M
-
Total reported value, excl. options
-
$2.31B
-
Value change
-
+$41.8M
-
Put/Call ratio
-
2.5
-
Number of buys
-
127
-
Number of sells
-
-61
-
Price
-
$33.04
Significant Holders of Beam Therapeutics Inc. - Common Stock (BEAM) as of Q1 2024
254 filings reported holding BEAM - Beam Therapeutics Inc. - Common Stock as of Q1 2024.
Beam Therapeutics Inc. - Common Stock (BEAM) has 220 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 70M shares
of 101M outstanding shares and own 69.63% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (8.18M shares), VANGUARD GROUP INC (7.58M shares), BlackRock Inc. (6.71M shares), FMR LLC (4.89M shares), FARALLON CAPITAL MANAGEMENT LLC (4.51M shares), MORGAN STANLEY (4.12M shares), STATE STREET CORP (3.73M shares), Sumitomo Mitsui Trust Holdings, Inc. (2.36M shares), Nikko Asset Management Americas, Inc. (2.36M shares), and MWG Management Ltd. (2.35M shares).
This table shows the top 220 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.